Hemifacial spasm in the Middle East: Insights from a high-volume tertiary care center
This first UAE study provides a detailed HFS profile, confirming high efficacy of botulinum toxin and microvascular decompression. Oral therapy may offer supportive, noninvasive benefit. Observed variations in onset age and etiology suggest potential genetic and environmental influences, highlighting the need for prospective multicenter studies in the region.
Authors
- E.D.C. Freitas (ORCID: https://orcid.org/0000-0001-8235-3229)
- Florian Röser (ORCID: https://orcid.org/0000-0002-7854-6789)
- Shivam Om Mittal (ORCID: https://orcid.org/0000-0003-2138-1108)
- Kiran Waqar
- M Thomas
- Yasmin Abdelmajed
Institutions
- Technology Innovation Institute (AE)
- Parkinson's and Movement Disorder Institute (US)
Publication Details
- Journal
- Clinical Neurology and Neurosurgery
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1016/j.clineuro.2025.109182
- Primary Topic
- Trigeminal Neuralgia and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00